勘误：Nectin-1高表达提示肝细胞癌预后不良并促进转移。
Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
作者信息
Wang Xuequan, Xing Ziming, Chen Huazhong, Yang Haihua, Wang Qiupeng, Xing Tongjing
机构信息
Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
出版信息
Front Oncol. 2023 Mar 21;13:1134139. doi: 10.3389/fonc.2023.1134139. eCollection 2023.
Abstract
[This corrects the article DOI: 10.3389/fonc.2022.953529.].
摘要
[本文更正了文章DOI：10.3389/fonc.2022.953529。]
相似文献
1
Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
Front Oncol. 2023 Mar 21;13:1134139. doi: 10.3389/fonc.2023.1134139. eCollection 2023.
2
Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
Front Oncol. 2021 Oct 15;11:785394. doi: 10.3389/fonc.2021.785394. eCollection 2021.
3
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
Front Oncol. 2022 Aug 22;12:979968. doi: 10.3389/fonc.2022.979968. eCollection 2022.
4
Corrigendum: LncRNA-AC02278.4 is a novel prognostic biomarker that promotes tumor growth and metastasis in lung adenocarcinoma.
Front Oncol. 2024 Mar 13;14:1390669. doi: 10.3389/fonc.2024.1390669. eCollection 2024.
5
Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
Front Oncol. 2022 Jan 17;11:843623. doi: 10.3389/fonc.2021.843623. eCollection 2021.
6
Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA.
Front Oncol. 2022 Jan 13;11:828861. doi: 10.3389/fonc.2021.828861. eCollection 2021.
7
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
Front Oncol. 2021 Nov 9;11:801970. doi: 10.3389/fonc.2021.801970. eCollection 2021.
8
Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma.
Front Oncol. 2023 Apr 19;13:1203745. doi: 10.3389/fonc.2023.1203745. eCollection 2023.
9
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Front Oncol. 2020 Nov 20;10:617539. doi: 10.3389/fonc.2020.617539. eCollection 2020.
10
Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Int J Clin Exp Pathol. 2013;6(2):179-90. Epub 2013 Jan 15.
Zotero 插件